+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID06525623

Study Comparing Two Intravenous Fluid Strategies for Treating Acute Kidney Injury in Adults With Cirrhosis Using a Volume Assessment Algorithm

Led by Massachusetts General Hospital · Updated on 2026-03-13

50

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating two approaches for giving intravenous IV fluids to patients with acute kidney injury AKI in cirrhosis. This pilot randomized trial compares a Volume Assessment Guidance Algorithm VAGA recommendation versus standard doses of IV albumin to study safety, effectiveness, and feasibility. The study focuses on patients with AKI and decompensated cirrhosis and measures outcomes like albumin amount used, kidney injury response, survival, and use of renal replacement therapy or liver transplant. Participants will be randomly assigned to receive either a one-time VAGA-based recommendation or standard care IV albumin at 1 gram per kilogram per day for two days, up to 100 grams per day. The VAGA group may be advised to stop fluid resuscitation, use crystalloid fluids, or use colloid fluids based on clinical guidelines. Both groups will be monitored at 48 hours after randomization, at hospital discharge, and 90 days post-randomization to assess albumin usage, adherence to guidance, and clinical outcomes. Participants will be evaluated through clinical assessments and data collection during hospital stay and follow-up visits. Researchers will track the amount of IV albumin given, adherence to the assigned treatment recommendations, kidney injury response, vital status, and events like renal replacement therapy or liver transplant up to 90 days. Safety outcomes including adverse events will be reviewed up to hospital discharge and 90 days. The total study duration for each participant includes hospitalization and a 90-day follow-up period.

CONDITIONS

Brief Title

Initial Resuscitation for Acute Kidney Injury in Cirrhosis

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here